BioCentury
ARTICLE | Financial News

Pluristem's deal with Chinese investor falls through

June 23, 2017 8:28 PM UTC

Pluristem Therapeutics Inc. (NASDAQ:PSTI; Tel Aviv:PSTI) disclosed that plans had been terminated for the company to receive a $30 million investment from China's Innovative Medical Management Co. Ltd. (SZSE:002173) (see BioCentury Extra, Oct. 25, 2016).

Pluristem said the deal fell through "due to a recently adopted Chinese policy relating to outbound investments by Chinese companies."...

BCIQ Company Profiles

Pluri Inc.